Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about IPSEY

Recent news which mentions IPSEY

FDA Fast-Tracks Ipsen And Genfit's New Liver Disease Treatment, Iqirvo
Tickers GNFT IPSEF IPSEY NEWS
Tags Market News IPSEY AI Generated
From Benzinga
3 Promising Biotech Stocks Flying Under the Radar
Tickers ABOS BMRN EXEL HALO
Tags BMRN IPSEY EXEL
From InvestorPlace
Third Time Lucky: Exelixis' Cabozantinib Combo Therapy Aces Pivotal Study In Prostate Cancer Patients
Tickers EXEL IPSEF IPSEY RHHBF
Tags RHHBY IPSEY Market News
From Benzinga
Genfit's Miss Is CymaBay Therapeutics' Gain: Analyst Says Rival Data Leaves Room for Seladelpar To Emerge As Best-In-Class
Tickers CBAY GNFT IPSEY
Tags Analyst Color Market News Analyst Ratings
From Benzinga
Ipsen, Genfit's Elafibranor Shows Promise In Primary Biliary Cholangitis Patients
Tickers GNFT IPSEY
Tags Market News IPSEY Penny Stocks
From Benzinga
What Now After FDA AdComm Rebuke for Intercept Pharmaceutical? Analyst Says Approval Of Intercept's 'OCA In NASH May Never Occur
Tickers CBAY DRRX GNFT ICPT
Tags Benzinga Biotech Movers
From Benzinga
Why These Two Biotech Stocks Blasted Higher This Week
Tickers ALBO AZN CINC IPSEY
Tags AZN IPSEY ALBO
From Motley Fool
2 Tiny Nasdaq Stocks Making Major Merger Moves Monday
Tickers ALBO DCT IPSEY
Tags ALBO Recent Press Releases IPSEY
From Motley Fool
France-Based Ipsen Acquires Albireo Pharma Enriching Its Rare Disease Portfolio, Pipeline
Tickers ALBO IPSEF IPSEY
Tags Biotech Movers Benzinga
From Benzinga
Exelixis' Cabometyx/Tecentriq Combo Misses Overall Survival Goal In Lung Cancer Setting
Tickers EXEL IPSEY RHHBY TAK
Tags Benzinga Health Care TAK
From Benzinga
Why Merrimack Shares Are Surging Over 200% Today?
Tickers IPSEF IPSEY MACK
Tags Briefs premarket trading Movers
From Benzinga
Provention Bio's Second Try, Apellis's Eye Disorder Drug Review, 3 Adcom Verdicts And More: November's Key PDUFA Catalysts Biotech Investors Must Know
Tickers APLS ARDX AZN FOLD
Tags PRVB ARDX IBB
From Benzinga
AstraZeneca-Merck's Prostate Cancer Combo Drug, 3rd Try For scPharma, 3 FDA Panel Decisions And More: October's Key PDUFA Catalysts Biotech Investors Must Know
Tickers ALNY AMLX AZN BLUE
Tags IBB FDA GSK
From Benzinga
Genfit To Buy This Swiss Firm Expanding Its Portfolio in Liver Diseases
Tickers GNFT IPSEY
Tags News Trading Ideas Penny Stocks
From Benzinga
Merrimack Pharma-Ipsen's Cancer Drug Fails In Overall Survival Measure
Tickers IPSEF IPSEY MACK
Tags Market News IPSEY why it's moving
From Benzinga
This Healthcare Stock Jumps Around 188%, Here's 83 Biggest Movers From Yesterday
Tickers AFIB AGRX AGTC AMST
Tags STSA OMER FNHC
From Benzinga
Why Adaptimmune Therapeutics Stock Is Popping Today
Tickers ADAP EPZM IPSEY
Tags IPSEY EPZM Recent Press Releases
From Motley Fool
Why Is NeuroSense Therapeutics Surging By 70%? 46 Stocks Moving In Monday's Mid-Day Session
Tickers AFIB AGRX AGTC ARMP
Tags IPSEY BHIL Markets
From Benzinga
Why Epizyme Stock Is Soaring Today
Tickers EPZM IPSEY
Tags Recent Press Releases Market News EPZM
From Motley Fool
The Daily Biotech Pulse: CHMP Backs AstraZeneca's Breast Cancer Therapies, Ipsen Buys Epizyme, FDA Holds For Nuvation Bio, Astellas Studies
Tickers ALPMF ALPMY AXSM AZN
Tags PFE Benzinga MITO
From Benzinga
Ipsen Scoops Up Blood Cancer-Focused Epizyme - Read Why
Tickers EPZM IPSEF IPSEY
Tags IPSEF General Briefs
From Benzinga
Buying These 3 Stocks Could Be the Smartest Investing Move You Ever Make
Tickers BMY ETSY EXEL IPSEY
Tags BMY IPSEY Market News
From Motley Fool
The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs
Tickers ACAD AQST BIIB BLTE
Tags Guidance INCY TARS
From Benzinga
Ipsen - Exelixis' Cabometyx Scores European Approval As Second-Line Treatment For Thyroid Cancer
Tickers EXEL IPSEF IPSEY
Tags EXEL Briefs News
From Benzinga
EMA's Scientific Committee Backs Expanded Use Of Exelixis, Ipsen's Cabometyx In Thyroid Cancer
Tickers EXEL IPSEF IPSEY
Tags IPSEY IPSEF General
From Benzinga
Exelixis Will Not Pursue Untreated Liver Cancer Indication For Cabometyx Combo Therapy
Tickers BAYRY BAYZF EXEL IPSEY
Tags RHHBF Liver Cancer General
From Benzinga
A Peek Into The Markets: US Stock Futures Down Following Friday's Plunge
Tickers ABBV GILD HAL IBM
Tags IPSEY Eurozone Global
From Benzinga
Ipsen's Sohonos Scores Canadian Approval For Rare Connective Tissue Disease
Tickers IPSEF IPSEY
Tags Market News IPSEY General
From Benzinga
GNFT Stock Alert: 15 Things to Know About Biotech Penny Stock Genfit as Shares Go Gangbusters
Tickers BABA FUTU GNFT IPSEY
Tags NVAX Market News BABA
From InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Tickers ABEO ADGI BLIN CERN
Tags MOXC Market News PLIN
From InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.